Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

J. Albanell, A. González, M. Ruiz-borrego, E. Alba, J. A. García-saenz, J. M. Corominas, O. Burgues, V. Furio, A. Rojo, J. Palacios, B. Bermejo, M. Martínez-garcía, M. L. Limon, A. S. Muñoz, M. Martín, I. Tusquets, F. Rojo, R. Colomer, I. Faull, A. Lluch